https://www.indianpharmapost.com/shilpa-medicare-raises-over-rs-297-crore-through-preferential-allotment-104562021-10-15T00:00:00+05:30always0.9https://www.indianpharmapost.com/exelixis-in-licenses-second-anti-cancer-compound-from-aurigene-104572021-10-15T00:00:00+05:30always0.9https://www.indianpharmapost.com/aum-biosciences-closes-us-27-million-series-a-funding-round-104582021-10-15T00:00:00+05:30always0.9https://www.indianpharmapost.com/expect-normal-quarter-in-q2fy22-emkay-104592021-10-15T00:00:00+05:30always0.9https://www.indianpharmapost.com/govt-launches-one-health-surveillance-programme-104602021-10-15T00:00:00+05:30always0.9